Livent Co. (NYSE:LTHM) Shares Sold by DekaBank Deutsche Girozentrale

Posted by Defense World Staff on Oct 15th, 2023

DekaBank Deutsche Girozentrale lowered its position in Livent Co. (NYSE:LTHM – Free Report) by 20.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,160 shares of the company’s stock after selling 10,621 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Livent were worth $1,054,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of LTHM. US Bancorp DE grew its holdings in shares of Livent by 46.5% in the 1st quarter. US Bancorp DE now owns 21,176 shares of the company’s stock worth $552,000 after acquiring an additional 6,726 shares during the period. Cambridge Investment Research Advisors Inc. lifted its stake in Livent by 27.4% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 20,285 shares of the company’s stock valued at $529,000 after buying an additional 4,359 shares in the last quarter. HighTower Advisors LLC lifted its stake in Livent by 18.1% in the 1st quarter. HighTower Advisors LLC now owns 39,483 shares of the company’s stock valued at $1,033,000 after buying an additional 6,044 shares in the last quarter. Private Advisor Group LLC lifted its stake in Livent by 3.4% in the 1st quarter. Private Advisor Group LLC now owns 26,235 shares of the company’s stock valued at $684,000 after buying an additional 856 shares in the last quarter. Finally, PNC Financial Services Group Inc. lifted its stake in Livent by 7.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 39,016 shares of the company’s stock valued at $1,017,000 after buying an additional 2,726 shares in the last quarter. Institutional investors and hedge funds own 96.76% of the company’s stock.

Insider Transactions at Livent

In other news, CEO Paul W. Graves sold 59,244 shares of the company’s stock in a transaction on Tuesday, October 3rd. The stock was sold at an average price of $16.90, for a total transaction of $1,001,223.60. Following the completion of the sale, the chief executive officer now directly owns 336,418 shares in the company, valued at approximately $5,685,464.20. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.17% of the company’s stock.

Analysts Set New Price Targets

LTHM has been the topic of a number of recent research reports. HSBC reduced their target price on Livent from $37.00 to $33.50 in a research note on Friday, June 23rd. Piper Sandler reduced their target price on Livent from $38.00 to $33.00 and set an “overweight” rating on the stock in a research note on Friday, September 1st. Finally, KeyCorp reduced their target price on Livent from $34.00 to $32.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 3rd. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, Livent currently has an average rating of “Moderate Buy” and an average price target of $29.77.

Get Our Latest Analysis on LTHM

Livent Trading Down 3.7 %

Shares of Livent stock opened at $17.86 on Friday. Livent Co. has a fifty-two week low of $16.42 and a fifty-two week high of $35.81. The firm has a market cap of $3.21 billion, a PE ratio of 10.26, a P/E/G ratio of 0.22 and a beta of 1.85. The business’s fifty day moving average is $20.03 and its two-hundred day moving average is $22.98. The company has a quick ratio of 2.37, a current ratio of 3.76 and a debt-to-equity ratio of 0.15.

Livent (NYSE:LTHM – Get Free Report) last released its quarterly earnings data on Thursday, August 3rd. The company reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.05. The business had revenue of $235.80 million during the quarter, compared to the consensus estimate of $257.00 million. Livent had a return on equity of 26.79% and a net margin of 38.85%. Analysts anticipate that Livent Co. will post 2.14 earnings per share for the current year.

About Livent

(Free Report)

Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications.